Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in m

[News]

Mount Sinai researchers have discovered that a rheumatoid arthritis drug can block a metabolic pathway that occurs in tumors with a common cancer-causing gene mutation, offering a new possible therapy for aggressive cancers with few therapeutic options, according to a study to be published in Cancer Discovery.

More... (http://www.news-medical.net/news/20170303/Rheumatoid-arthritis-drug-blocks-metabolic-pathway-reduces-breast-cancer-tumors-in-mice.aspx)